Clinical trial
Special Drug Use Surveillance Study of Ceprotin for Intravenous Injection 1000IU (All-Case Surveillance)
NCT06590974 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Special Drug Use Surveillance Study of Ceprotin for Intravenous Injection 1000IU (All-Case Surveillance)
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 6, 2024
- Completion date
- June 30, 2030
- Enrollment
- 7 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.